UTHR

#502
United Therapeutics Corp
575.12 USD
-0.43%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
573.84
577.05
Intervallo Annuale
272.17
607.89
Variazione giornaliera
-0.43%
Variazione Mensile
+7.16%
Variazione di 6 mesi
+32.69%
Variazione Annuale
+102.32%
Chiusura Precedente
577.63
Apertura
575.00
Bid
Ask
Minimo
573.84
High
577.05
Volume
65
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 25.21 B
  • Employee 1 400
  • Founded 1996
  • CEO N/A
  • Website www.unither.com
  • Headquarter Delaware, United States
  • FIGI BBG000BV4XJ1
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
17.49
Rapporto prezzo/fatturato
7.33

United Therapeutics Corporation - Common Stock

United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.

Notizie